Anticholinergic Drugs in Nonallergic Rhinitis

World Allergy Organization Journal

Robert Naclerio¹ 

[1] Section of Otolaryngology--Head and Neck Surgery, The University of Chicago, Chicago, IL

关键词: nonallergic rhinitis;    rhinitis;    ipratropium bromide;    atropine;    anticholinergic;   

Others  :  1180847
DOI  :  10.1097/WOX.0b013e3181b35336

【 摘 要 】

Background

The parasympathetic nervous system contributes to the pathophysiology of multiple forms of allergic and nonallergic rhinitis. Stimulation of the parasympathetic nervous system leads to glandular activation, which produces watery secretions. In excess, these secretions discharge from the anterior Nares and produce the symptom of watery anterior rhinorrhea.

Method

Review of literature.

Results

Treatment with topical, intranasal anticholinergic drugs inhibits activation of the nasal mucosal glands and is effective in reducing the watery secretions associated with parasympathetic stimulation of the glands with little, if any, effect on the symptoms of congestion and sneezing. In general, these drugs have no systemic adverse effects, but can cause crusting and local irritation.

Conclusion

Anticholinergic drugs are useful for the treatment of anterior rhinorrhea associated with allergic and nonallergic rhinitis.

【 授权许可】

   
2009 World Allergy Organization; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Sarin S, Undem B, Sanico A, Togias A: The role of the nervous system in rhinitis. J Allergy Clin Immunol 2006, 118:999-1014.
• [2]Yang B, McCaffrey TV: The roles of muscarinic receptor subtypes in modulation of nasal ciliary action. Rhinology 1996, 34:136-139.
• [3]Becker B, Borum S, Nielsen K, Mygind N, Borum P: A time dose-study of the effect of topical ipratropium bromide on the methacholine-induced rhinorrhea in patients with perennial non-allergic rhinitis. Clin Otolaryngol 1997, 22:132-134.
• [4]Wagenmann M, Baroody FM, Jankowski R, Nadal JC, Roecker-Cooper M, et al.: Onset and duration of inhibition of ipratropium nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy 1994, 24:288-290.
• [5]Ingelstedt S, Ivstam B: Study in the humidifying capacity of the nose. Acta Otolaryngol (Stockholm) 1951, 39:286-289.
• [6]Kumlien J, Drettner B: The effect of ipratropium bromide (atrovent) on the air conditioning capacity of the nose. Clin Otolaryngol 1985, 10:165-168.
• [7]Assanasen P, Baroody FM, Rouadi P, Naureckas E, Solway J, Naclerio RM: Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med 2000, 162:1031-1037.
• [8]Georgitis JW: Nasal atropine sulfate. Arch Otolaryngol Head Neck Surg 1998, 124:916-920.
• [9]Georgitis JW: The anticholinergic treatment of allergic perennial rhinitis. J Allergy Clin Immunol 1992, 90:1071-1076.
• [10]Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, et al.: The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Allergy Asthma Proc 1998, 19:23-29.
• [11]Mygind N, Borum P: Effect of a cholinergic-ceptor antagonist in the nose. Eur J Respir Dis 1983, 64(Suppl 128):167-174.
• [12]Bonadonna P, Senna G, Zanon P, Cocco G, Dorizzi R, et al.: Cold-induced rhinitis in skiers: clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol 2001, 15:297-301.
• [13]Silvers WS: The skier's nose: a model of cold-induced rhinorrhea. Ann Allergy 1991, 67:32-36.
• [14]Ostberg B, Winther B, Borum P, Mygind N: Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. Rhinology 1997, 35:58-62.
• [15]Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT: Effectiveness and safety of intranasal ipratropium bromide in common colds. Ann Intern Med 1996, 125:89-97.
• [16]Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, et al.: Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Ann Allergy Asthma Immunol 2005, 94:73-79.
• [17]Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, et al.: Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999, 82:349-359.
• [18]Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjarne P: Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol 2007, 21:40-45.
• [19]Finn AF Jr, Aaronson D, Korenblat P, Lumry W, Settipane G, et al.: Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial. Am J Rhinol 1998, 12:441-449.
• [20]Settipane RA, Lieberman P: Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001, 86:494-508.
• [21]Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM: Local application of atropine attenuates the upper airway reaction to cold-dry air. Am Rev Respir Dis 1992, 146:340-346.
• [22]Shusterman D, Murphy M-A, Walsh P, Balmes JR: Cholinergic blockade does not alter the nasal congestive response to irritant provocation. Rhinology 2003, 40:141-146.
• [23]McLean JA, Mathews KP, Solomon WR, Brayton PR, Bayne NK: Effect of ammonia on nasal resistance in atopic and nonatopic subjects. Ann Otol 1979, 88:228-234.
• [24]Stjarne P, Lundblad L, Lundberg JM, Anggard A: Capsaicin and nicotine-sensitive afferent neurons and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989, 96:693-701.
• [25]Raphael G, Raphael MH, Kaliner M: Gustatory rhinitis: a syndrome of food-induced rhinorrhea. J Allergy Clin Immunol 1989, 83:110-115.
• [26]Baroody FB, Foster KA, Markaryan A, deTineo M, Naclerio RM: Nasal-ocular reflexes contribute to eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2008, 100:194-199.
• [27]Atrovent Thomson 62nd edition. 2008, 826-833. Physicians' Desk Reference
• [28]Kim K-S, Kim S-S, Yoon J-H, Han JW: The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998, 112:248-251.
• [29]Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM, Fokkens WJ: Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy 2003, 58:754-761.
• [30]Bhargava KB, Shirali GN, Abhhyankar US, Gadre KC: Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate. J Laryngol Otol 1992, 106:699-701.
• [31]al-Samarrae SM: Treatment of 'vasomotor rhinitis' by the local application of silver nitrate. J Laryngol Otol 1991, 105:285-287.
• [32]el-Guindy A: Endoscopic transseptal vidian neurectomy. Arch Otolaryngol Head Neck Surg 1994, 120:1347-1351.
• [33]Dong Z: Anterior ethmoidal electrocoagulation in the treatment of vasomotor rhinitis (Zhonhua Er Bi Yan Hou Ke Za Zhi). Chinese J Otorhinolaryngol 1991, 26:358-359. 383
• [34]Fernandes CM: Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol 1994, 108:569-573.